13th Molecules Webinar

Antibacterial Agents 2021

Multidrug resistant (MDR) bacteria represent one of the greatest threats to global health. The majority of drugs currently in clinical practice were introduced in the period between the 1950s and 1980s. Some Gram-negative bacteria have already acquired pandrug-resistance. Drug resistant Mycobacterium spp. remains one of the most difficult pathogens to cure without long treatment regimens. Spore-forming Bacillus spp. are very difficult to treat with marketed drugs. Such antibiotic resistances are threatening our ability to treat illnesses; however, the development of new antimicrobial agents is declining, due in large part, to the fact that research and development in large pharmaceutical industries have been targeted towards drug development of the leading chronic diseases in the last few decades. The continuous development of antibacterial agents is important to reduce the global threat of antibiotic resistance. In the last decade, antibacterial drug discovery has advanced to unique translational sciences, including target-oriented drug discovery, structural biochemistry, new synthetic methods, modern drug delivery approaches, novel screening methods, and high-throughput assay methods. This webinar will provide recent advances in the discovery of antibacterial agents in academia. The related Special Issue "Antibacterial Agents 2021", which will be published by the open access journal Molecules, is open for submission should you have a relevant paper ready for publication. More details can be found here.

Date: 15 July 2021

Time: 4:00pm CEST | 10:00am EDT | 10:00pm CST Asia

Webinar ID: 812 4138 3757

Webinar Secretariat: molecules.webinar@mdpi.com